Perioperative Management and Outcomes of Minimally Invasive Esophagectomy

Esophageal Cancer Clinical Trial

Official title:

Perioperative Management and Outcomes of Minimally Invasive Esophagectomy- Experience of a High-volume Tertiary Center in Taiwan

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03378869
• Other study ID #: 201708054RINB
• Status: Completed
• Phase: N/A
• First received: December 15, 2017
• Last updated: December 19, 2017
• Start date: June 1, 2017
• Est. completion date: September 15, 2017

Study information

• Verified date: December 2017
• Source: National Taiwan University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The investigators retrospectively reviewed the data of all patients who had undergone esophagectomy and reconstruction in 2015. Patient characteristics, the surgery performed, method of anesthesia, postoperative hospitalization course, and additional surgical interventions were reviewed and analyzed.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 64
• Est. completion date: September 15, 2017
• Est. primary completion date: August 1, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria:

• patients received esophageal reconstruction in 2015.

Exclusion Criteria:

• age <18

• not malignancy

Related Conditions & MeSH terms

• Esophageal Cancer
• Esophageal Neoplasms

Intervention

Procedure:
• esophagectomy
all the included participants had received esophagectomy, either Ivor Lewis or tri-incision, or more complex procedures.

Locations

Country	Name	City	State
Taiwan	NTUH	Taipei

Sponsors (1)

Lead Sponsor	Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	30-day mortality	rate of 30-day mortality	30 day after surgery